Baker Biotech Capital (GP), LLC Insider Trading $SGEN Seagen Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Baker Biotech Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Biotech Capital (GP), LLC. Baker Biotech Capital (GP), LLC is 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX).
Baker Biotech Capital (GP), LLC in Seagen Inc.
Trading Symbol: SGENIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Biotech Capital (GP), LLC: Director
Holdings: 1,535,999 shares
Current Value: $93,373,379
Latest Transaction: Aug 16 2006
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Baker Biotech Capital (GP), LLC in Seagen Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IBPI, GHDX, SGEN
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 16 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.05 | 12,080 | 48,924 | 1,535,999 | 1.5 M to 1.5 M (+0.79 %) |
Aug 10 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.05 | 11,838 | 47,943 | 1,480,319 | 1.5 M to 1.5 M (+0.81 %) |
Aug 10 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.05 | 51,819 | 209,867 | 1,468,481 | 1.4 M to 1.5 M (+3.66 %) |
Aug 10 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.05 | 2,416 | 9,779 | 1,416,662 | 1.4 M to 1.4 M (+0.17 %) |
Aug 15 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.03 | 34,745 | 139,991 | 1,523,919 | 1.5 M to 1.5 M (+2.33 %) |
Aug 15 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.03 | 834 | 3,361 | 1,489,174 | 1.5 M to 1.5 M (+0.06 %) |
Aug 15 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.04 | 338 | 1,364 | 1,488,340 | 1.5 M to 1.5 M (+0.02 %) |
Aug 15 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 3.70 | 7,683 | 28,419 | 1,400,741 | 1.4 M to 1.4 M (+0.55 %) |
Aug 08 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.03 | 9,350 | 37,719 | 1,414,246 | 1.4 M to 1.4 M (+0.67 %) |
Aug 08 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.05 | 5,798 | 23,481 | 1,404,896 | 1.4 M to 1.4 M (+0.41 %) |
Aug 08 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.00 | 6,040 | 24,140 | 1,399,098 | 1.4 M to 1.4 M (+0.43 %) |
Jun 29 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.08 | 20,340 | 82,922 | 1,393,058 | 1.4 M to 1.4 M (+1.48 %) |
Jun 29 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.02 | 77,345 | 310,726 | 1,372,718 | 1.3 M to 1.4 M (+5.97 %) |
Jun 29 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.04 | 31,943 | 128,948 | 1,295,373 | 1.3 M to 1.3 M (+2.53 %) |
Jun 29 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.03 | 354 | 1,427 | 1,263,430 | 1.3 M to 1.3 M (+0.03 %) |
Jun 27 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.00 | 34,216 | 136,919 | 1,263,076 | 1.2 M to 1.3 M (+2.78 %) |
Jun 27 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.07 | 8,639 | 35,138 | 1,228,860 | 1.2 M to 1.2 M (+0.71 %) |
Jun 27 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.05 | 4,958 | 20,089 | 1,220,221 | 1.2 M to 1.2 M (+0.41 %) |
Jun 27 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.06 | 2,722 | 11,054 | 1,215,263 | 1.2 M to 1.2 M (+0.22 %) |
Jun 21 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.07 | 12,220 | 49,776 | 1,212,541 | 1.2 M to 1.2 M (+1.02 %) |
Jun 21 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.00 | 7,074 | 28,271 | 1,200,321 | 1.2 M to 1.2 M (+0.59 %) |
Jun 21 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 3.99 | 9,043 | 36,095 | 1,193,247 | 1.2 M to 1.2 M (+0.76 %) |
Jun 21 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.00 | 7,793 | 31,156 | 1,184,204 | 1.2 M to 1.2 M (+0.66 %) |
Jun 21 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.00 | 2,102 | 8,399 | 1,176,411 | 1.2 M to 1.2 M (+0.18 %) |
Jun 13 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.04 | 9,649 | 39,025 | 1,174,309 | 1.2 M to 1.2 M (+0.83 %) |
Jun 13 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.02 | 13,066 | 52,474 | 1,164,660 | 1.2 M to 1.2 M (+1.13 %) |
Jun 13 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 3.90 | 6,110 | 23,829 | 1,151,594 | 1.1 M to 1.2 M (+0.53 %) |
Jun 13 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.00 | 460,379 | 1,841,516 | 1,145,484 | 685.1 K to 1.1 M (+67.20 %) |
Jun 13 2006 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.11 | 17,817 | 73,228 | 685,105 | 667.3 K to 685.1 K (+2.67 %) |
Page: 1